Truist Securities analyst Greg Renza raised the price target on CG Oncology (NASDAQ: CGON) to $82.00 (from $77.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE